PARATI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 61.977
EU - Europa 27.952
AS - Asia 16.831
SA - Sud America 1.510
AF - Africa 177
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 44
Totale 108.578
Nazione #
US - Stati Uniti d'America 61.019
SG - Singapore 6.745
RU - Federazione Russa 5.618
CN - Cina 4.546
IT - Italia 4.213
SE - Svezia 4.062
IE - Irlanda 4.055
DE - Germania 3.786
HK - Hong Kong 3.383
UA - Ucraina 2.310
GB - Regno Unito 1.294
BR - Brasile 1.175
CA - Canada 824
FI - Finlandia 684
VN - Vietnam 538
ID - Indonesia 479
FR - Francia 463
AT - Austria 333
NL - Olanda 289
IN - India 264
TR - Turchia 230
DK - Danimarca 200
BE - Belgio 126
JP - Giappone 104
ES - Italia 77
AU - Australia 72
MX - Messico 72
KR - Corea 71
IR - Iran 66
PE - Perù 65
ZA - Sudafrica 63
CL - Cile 58
CZ - Repubblica Ceca 58
AR - Argentina 56
PL - Polonia 56
RO - Romania 50
EC - Ecuador 48
CH - Svizzera 45
PT - Portogallo 44
CO - Colombia 43
BD - Bangladesh 39
TW - Taiwan 36
TH - Thailandia 33
BG - Bulgaria 28
EU - Europa 28
PK - Pakistan 28
VE - Venezuela 28
AE - Emirati Arabi Uniti 26
IQ - Iraq 25
UZ - Uzbekistan 25
HU - Ungheria 24
EG - Egitto 23
GR - Grecia 23
PH - Filippine 21
BO - Bolivia 19
NO - Norvegia 18
SA - Arabia Saudita 18
IL - Israele 16
MA - Marocco 16
GE - Georgia 15
AL - Albania 14
LV - Lettonia 14
AM - Armenia 13
AZ - Azerbaigian 13
KZ - Kazakistan 13
MY - Malesia 13
NZ - Nuova Zelanda 13
CR - Costa Rica 12
JO - Giordania 12
KG - Kirghizistan 12
TN - Tunisia 12
KE - Kenya 11
LK - Sri Lanka 11
LT - Lituania 11
NG - Nigeria 11
A2 - ???statistics.table.value.countryCode.A2??? 10
BY - Bielorussia 9
NP - Nepal 9
PA - Panama 9
DZ - Algeria 8
PY - Paraguay 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
SC - Seychelles 7
BB - Barbados 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HR - Croazia 6
JM - Giamaica 6
MD - Moldavia 6
UY - Uruguay 6
CU - Cuba 5
HN - Honduras 5
OM - Oman 5
EE - Estonia 4
GH - Ghana 4
SI - Slovenia 4
A1 - Anonimo 3
CY - Cipro 3
KW - Kuwait 3
Totale 108.512
Città #
Ann Arbor 10.712
Fairfield 6.278
Woodbridge 4.686
Singapore 4.496
Dublin 3.869
Chandler 3.818
Houston 3.708
Hong Kong 3.353
Ashburn 3.257
Wilmington 2.971
Frankfurt am Main 2.749
Jacksonville 2.604
Seattle 2.327
Cambridge 2.082
Dearborn 2.041
New York 1.837
Santa Clara 1.751
Princeton 1.739
Milan 1.181
Lawrence 833
Nanjing 794
Altamura 785
Beijing 597
San Diego 501
Shanghai 453
Jakarta 438
Lachine 375
Dong Ket 303
Boardman 286
Moscow 273
Hangzhou 260
Guangzhou 250
Nanchang 243
Vienna 242
Shenyang 239
Andover 235
Council Bluffs 219
Helsinki 209
Toronto 205
Hebei 180
London 174
Nuremberg 152
Jiaxing 147
Norwalk 147
Ottawa 145
Tianjin 144
Los Angeles 130
Changsha 129
Falls Church 118
Brussels 113
Jinan 113
Rome 112
São Paulo 95
Mountain View 86
Huizen 85
Lappeenranta 83
Zhengzhou 80
Hefei 77
Fremont 76
Kunming 72
Chicago 67
Washington 66
Detroit 63
Dallas 61
Ningbo 55
Phoenix 51
Belo Horizonte 47
Düsseldorf 44
Pune 44
Munich 43
Redmond 43
Saint Petersburg 43
Taizhou 43
Edmonton 42
Perugia 42
San Mateo 42
Bologna 41
Kilburn 40
Amsterdam 35
Rio de Janeiro 34
Turin 34
Brno 31
Sacramento 31
Wuhan 30
Lima 29
Tokyo 29
Fuzhou 28
Groningen 28
Naples 28
Chiswick 27
Kiev 26
University Park 26
Clearwater 25
Bergamo 24
Berlin 24
Bonndorf 24
Brasília 24
Kraków 24
Leawood 24
Santiago 24
Totale 77.143
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 443
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 418
May Measurement Month 2017: an analysis of blood pressure screening results worldwide 406
Blood pressure and high altitude: physiological response and clinical management [Presión arterial y altitud: respuestas fisiológicas y manejo clínico] 385
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 371
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 353
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 335
Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines 314
Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe 309
Aldosterone-To-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment 297
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 294
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke 293
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 291
Calcium antagonists and neural control of circulation in essential hypertension 281
Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns 280
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 270
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 268
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 260
Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects 260
An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study 258
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 254
Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. 251
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 250
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the european society of cardiology, the council on hypertension of the european society of cardiology, the european society of hypertension, the international society of mountain medicine, the Italian society of hypertension and the Italian society of mountain medicine 250
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 247
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 246
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 242
Blood pressure variability and obstructive sleep apnea. A question of phenotype? 238
Cap. 8: Cuore e malattie sistemiche 235
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 234
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 232
Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment 230
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 230
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 229
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 226
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 226
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 225
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 225
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 224
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis 224
Noninvasive Estimation of Aortic Stiffness Through Different Approaches: Comparison with Intra-Aortic Recordings 223
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials 222
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 221
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 215
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 215
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal 214
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 212
Modification of arterial baroreflexes by captopril in essential hypertension 212
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 212
Hemodynamic and Autonomic Response to Different Salt Intakes in Normotensive Individuals 210
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 210
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010 209
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 209
Heart failure and anemia: Effects on prognostic variables 208
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 206
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension 205
Control of blood pressure by carotid sinus baroreceptors in human beings 203
Circulating factors are involved in hypoxia-induced hepcidin suppression 200
Predicting Depression from Illness Severity in Cardiovascular Disease Patients: Self-efficacy Beliefs, Illness Perception, and Perceived Social Support as Mediators 200
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 199
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 199
Intra-aortic balloon pump for treatment of refractory ventricular tachycardia in Tako-Tsubo cardiomyopathy: A case report 198
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 198
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 197
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 197
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 196
Effects of device-guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure 196
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 196
Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study 196
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 195
Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis 195
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 194
Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects 194
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 194
Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from 16-day spaceflight 193
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 192
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 191
Prevalence of hypertension and cardiovascular risk factors in chinese migrating to Milan as compared to a northern italian population 191
Intermittent levosimendan infusions in advanced heart failure: a real world experience 191
Prognostic value of baroreflex sensitivity in heart failure. A 2018 reappraisal 191
Reduction of 24-h blood pressure variability in extreme obese patients 10 days and 6 months after bariatric surgery depending on pre-existing hypertension 191
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 191
Alerting reaction and rise in blood pressure during measurement by physician and nurse 191
Clinical and psychological telemonitoring and telecare of high risk heart failure patients 191
Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness 190
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) 190
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 189
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: Data from HIGHCARE study on Mount Everest 189
Short-Term Repeatability of Noninvasive Aortic Pulse Wave Velocity Assessment: Comparison between Methods and Devices 187
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 186
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 185
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database 185
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure 184
Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study 184
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 184
High-altitude hypoxia and periodic breathing during sleep: gender related differences 183
Mechanisms of obesity-induced hypertension 183
Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure 183
Isolated systolic hypertension in the young: A position paper endorsed by the European Society of Hypertension 183
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 182
Totale 22.934
Categoria #
all - tutte 457.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 457.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.513 0 0 0 0 0 0 0 0 0 1.005 1.074 434
2020/202115.317 967 759 1.600 1.602 1.140 1.364 1.581 1.547 1.371 1.428 737 1.221
2021/202211.977 750 1.116 1.755 955 812 626 659 684 634 798 1.160 2.028
2022/202316.288 2.161 4.384 1.536 1.313 1.067 2.717 208 845 1.064 196 448 349
2023/202412.193 352 463 433 498 1.787 3.172 2.305 306 1.112 224 207 1.334
2024/202522.377 1.931 3.853 1.525 1.417 2.753 1.227 1.740 1.263 3.581 3.087 0 0
Totale 112.340